Clinical Trial Update: Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluates a rebeccamycin analog in combination with cisplatin, with or without filgrastim, in patients with advanced cancer including lymphoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Filgrastim (filgrastim)
• Rebeccamycin analog (rebeccamycin analog)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED